nodes	percent_of_prediction	percent_of_DWPC	metapath
Pralidoxime—ACHE—Irinotecan—lung cancer	0.395	0.478	CbGbCtD
Pralidoxime—BCHE—Irinotecan—lung cancer	0.238	0.288	CbGbCtD
Pralidoxime—BCHE—Cisplatin—lung cancer	0.194	0.235	CbGbCtD
Pralidoxime—BCHE—diaphragm—lung cancer	0.0164	0.615	CbGeAlD
Pralidoxime—Diplopia—Crizotinib—lung cancer	0.00359	0.0401	CcSEcCtD
Pralidoxime—Muscular weakness—Crizotinib—lung cancer	0.00317	0.0354	CcSEcCtD
Pralidoxime—Inflammation—Erlotinib—lung cancer	0.00277	0.0309	CcSEcCtD
Pralidoxime—Haemoglobin—Gefitinib—lung cancer	0.00227	0.0253	CcSEcCtD
Pralidoxime—Haemorrhage—Gefitinib—lung cancer	0.00225	0.0252	CcSEcCtD
Pralidoxime—Vision blurred—Crizotinib—lung cancer	0.00204	0.0228	CcSEcCtD
Pralidoxime—BCHE—respiratory system—lung cancer	0.00187	0.0703	CbGeAlD
Pralidoxime—Haemoglobin—Teniposide—lung cancer	0.00185	0.0207	CcSEcCtD
Pralidoxime—Haemorrhage—Teniposide—lung cancer	0.00184	0.0206	CcSEcCtD
Pralidoxime—Inflammation—Etoposide—lung cancer	0.00164	0.0184	CcSEcCtD
Pralidoxime—BCHE—bronchus—lung cancer	0.00154	0.0578	CbGeAlD
Pralidoxime—Muscular weakness—Vinorelbine—lung cancer	0.00149	0.0166	CcSEcCtD
Pralidoxime—Agitation—Teniposide—lung cancer	0.00147	0.0164	CcSEcCtD
Pralidoxime—Haemoglobin—Vinblastine—lung cancer	0.00141	0.0158	CcSEcCtD
Pralidoxime—Haemorrhage—Vinblastine—lung cancer	0.0014	0.0157	CcSEcCtD
Pralidoxime—BCHE—trachea—lung cancer	0.00138	0.0519	CbGeAlD
Pralidoxime—ACHE—lymph node—lung cancer	0.00138	0.0519	CbGeAlD
Pralidoxime—Pain—Pemetrexed—lung cancer	0.00138	0.0154	CcSEcCtD
Pralidoxime—Pain—Gefitinib—lung cancer	0.00137	0.0153	CcSEcCtD
Pralidoxime—Haemoglobin—Topotecan—lung cancer	0.00137	0.0153	CcSEcCtD
Pralidoxime—Inflammation—Docetaxel—lung cancer	0.00136	0.0153	CcSEcCtD
Pralidoxime—Haemorrhage—Topotecan—lung cancer	0.00136	0.0152	CcSEcCtD
Pralidoxime—Haemoglobin—Erlotinib—lung cancer	0.00135	0.0151	CcSEcCtD
Pralidoxime—Haemorrhage—Erlotinib—lung cancer	0.00135	0.0151	CcSEcCtD
Pralidoxime—BCHE—cardiac atrium—lung cancer	0.0013	0.0488	CbGeAlD
Pralidoxime—Tachycardia—Teniposide—lung cancer	0.00127	0.0142	CcSEcCtD
Pralidoxime—Hyperventilation—Doxorubicin—lung cancer	0.0012	0.0134	CcSEcCtD
Pralidoxime—Dizziness—Crizotinib—lung cancer	0.00117	0.013	CcSEcCtD
Pralidoxime—BCHE—bone marrow—lung cancer	0.0011	0.0412	CbGeAlD
Pralidoxime—Dizziness—Pemetrexed—lung cancer	0.00107	0.0119	CcSEcCtD
Pralidoxime—Nausea—Crizotinib—lung cancer	0.00105	0.0117	CcSEcCtD
Pralidoxime—Muscular weakness—Paclitaxel—lung cancer	0.000999	0.0112	CcSEcCtD
Pralidoxime—BCHE—lung—lung cancer	0.000994	0.0373	CbGeAlD
Pralidoxime—Inflammation—Methotrexate—lung cancer	0.000983	0.011	CcSEcCtD
Pralidoxime—Haemoglobin—Irinotecan—lung cancer	0.000966	0.0108	CcSEcCtD
Pralidoxime—Haemorrhage—Irinotecan—lung cancer	0.000961	0.0107	CcSEcCtD
Pralidoxime—Nausea—Pemetrexed—lung cancer	0.000958	0.0107	CcSEcCtD
Pralidoxime—Nausea—Gefitinib—lung cancer	0.000952	0.0106	CcSEcCtD
Pralidoxime—Haemoglobin—Gemcitabine—lung cancer	0.000941	0.0105	CcSEcCtD
Pralidoxime—Haemorrhage—Gemcitabine—lung cancer	0.000936	0.0105	CcSEcCtD
Pralidoxime—Pain—Vinblastine—lung cancer	0.000852	0.00953	CcSEcCtD
Pralidoxime—Inflammation—Doxorubicin—lung cancer	0.000851	0.00952	CcSEcCtD
Pralidoxime—Pain—Topotecan—lung cancer	0.000828	0.00925	CcSEcCtD
Pralidoxime—Pain—Erlotinib—lung cancer	0.000819	0.00916	CcSEcCtD
Pralidoxime—Headache—Teniposide—lung cancer	0.000818	0.00915	CcSEcCtD
Pralidoxime—Tachycardia—Vinorelbine—lung cancer	0.000808	0.00903	CcSEcCtD
Pralidoxime—Haemoglobin—Paclitaxel—lung cancer	0.000788	0.00881	CcSEcCtD
Pralidoxime—Haemorrhage—Paclitaxel—lung cancer	0.000784	0.00876	CcSEcCtD
Pralidoxime—Nausea—Teniposide—lung cancer	0.000776	0.00867	CcSEcCtD
Pralidoxime—Vision blurred—Cisplatin—lung cancer	0.000716	0.008	CcSEcCtD
Pralidoxime—Pain—Vinorelbine—lung cancer	0.000708	0.00792	CcSEcCtD
Pralidoxime—BCHE—lymph node—lung cancer	0.00068	0.0255	CbGeAlD
Pralidoxime—Haemoglobin—Docetaxel—lung cancer	0.000668	0.00747	CcSEcCtD
Pralidoxime—Haemorrhage—Docetaxel—lung cancer	0.000664	0.00743	CcSEcCtD
Pralidoxime—Dizziness—Vinblastine—lung cancer	0.000659	0.00737	CcSEcCtD
Pralidoxime—Vision blurred—Paclitaxel—lung cancer	0.000643	0.00719	CcSEcCtD
Pralidoxime—Dizziness—Topotecan—lung cancer	0.00064	0.00716	CcSEcCtD
Pralidoxime—Dizziness—Erlotinib—lung cancer	0.000633	0.00708	CcSEcCtD
Pralidoxime—Agitation—Paclitaxel—lung cancer	0.000627	0.00701	CcSEcCtD
Pralidoxime—Headache—Vinblastine—lung cancer	0.000624	0.00698	CcSEcCtD
Pralidoxime—Somnolence—Irinotecan—lung cancer	0.000607	0.00679	CcSEcCtD
Pralidoxime—Headache—Topotecan—lung cancer	0.000606	0.00678	CcSEcCtD
Pralidoxime—Tachycardia—Cisplatin—lung cancer	0.000605	0.00677	CcSEcCtD
Pralidoxime—Headache—Erlotinib—lung cancer	0.0006	0.00671	CcSEcCtD
Pralidoxime—Diplopia—Doxorubicin—lung cancer	0.000599	0.0067	CcSEcCtD
Pralidoxime—Nausea—Vinblastine—lung cancer	0.000592	0.00662	CcSEcCtD
Pralidoxime—Somnolence—Gemcitabine—lung cancer	0.000591	0.00661	CcSEcCtD
Pralidoxime—Pain—Irinotecan—lung cancer	0.000584	0.00653	CcSEcCtD
Pralidoxime—Nausea—Topotecan—lung cancer	0.000575	0.00643	CcSEcCtD
Pralidoxime—Pain—Gemcitabine—lung cancer	0.000569	0.00636	CcSEcCtD
Pralidoxime—Nausea—Erlotinib—lung cancer	0.000569	0.00636	CcSEcCtD
Pralidoxime—Tachycardia—Etoposide—lung cancer	0.000554	0.0062	CcSEcCtD
Pralidoxime—Dizziness—Vinorelbine—lung cancer	0.000548	0.00612	CcSEcCtD
Pralidoxime—Tachycardia—Paclitaxel—lung cancer	0.000544	0.00608	CcSEcCtD
Pralidoxime—Drowsiness—Methotrexate—lung cancer	0.000533	0.00596	CcSEcCtD
Pralidoxime—Pain—Cisplatin—lung cancer	0.00053	0.00593	CcSEcCtD
Pralidoxime—Muscular weakness—Doxorubicin—lung cancer	0.000529	0.00591	CcSEcCtD
Pralidoxime—Headache—Vinorelbine—lung cancer	0.000519	0.0058	CcSEcCtD
Pralidoxime—Somnolence—Etoposide—lung cancer	0.000505	0.00565	CcSEcCtD
Pralidoxime—Somnolence—Paclitaxel—lung cancer	0.000495	0.00554	CcSEcCtD
Pralidoxime—Nausea—Vinorelbine—lung cancer	0.000492	0.0055	CcSEcCtD
Pralidoxime—Pain—Etoposide—lung cancer	0.000486	0.00543	CcSEcCtD
Pralidoxime—Haemoglobin—Methotrexate—lung cancer	0.000481	0.00538	CcSEcCtD
Pralidoxime—Haemorrhage—Methotrexate—lung cancer	0.000479	0.00535	CcSEcCtD
Pralidoxime—Pain—Paclitaxel—lung cancer	0.000476	0.00532	CcSEcCtD
Pralidoxime—Drowsiness—Doxorubicin—lung cancer	0.000462	0.00516	CcSEcCtD
Pralidoxime—Tachycardia—Docetaxel—lung cancer	0.000461	0.00515	CcSEcCtD
Pralidoxime—Dizziness—Irinotecan—lung cancer	0.000452	0.00505	CcSEcCtD
Pralidoxime—Headache—Irinotecan—lung cancer	0.000428	0.00478	CcSEcCtD
Pralidoxime—Somnolence—Docetaxel—lung cancer	0.00042	0.00469	CcSEcCtD
Pralidoxime—Haemoglobin—Doxorubicin—lung cancer	0.000417	0.00466	CcSEcCtD
Pralidoxime—Headache—Gemcitabine—lung cancer	0.000417	0.00466	CcSEcCtD
Pralidoxime—Haemorrhage—Doxorubicin—lung cancer	0.000415	0.00464	CcSEcCtD
Pralidoxime—Nausea—Irinotecan—lung cancer	0.000406	0.00453	CcSEcCtD
Pralidoxime—Pain—Docetaxel—lung cancer	0.000404	0.00451	CcSEcCtD
Pralidoxime—Nausea—Gemcitabine—lung cancer	0.000395	0.00442	CcSEcCtD
Pralidoxime—Vision blurred—Methotrexate—lung cancer	0.000393	0.00439	CcSEcCtD
Pralidoxime—Dizziness—Etoposide—lung cancer	0.000376	0.0042	CcSEcCtD
Pralidoxime—Dizziness—Paclitaxel—lung cancer	0.000368	0.00412	CcSEcCtD
Pralidoxime—Nausea—Cisplatin—lung cancer	0.000368	0.00412	CcSEcCtD
Pralidoxime—Headache—Etoposide—lung cancer	0.000356	0.00398	CcSEcCtD
Pralidoxime—Headache—Paclitaxel—lung cancer	0.000349	0.0039	CcSEcCtD
Pralidoxime—Vision blurred—Doxorubicin—lung cancer	0.00034	0.0038	CcSEcCtD
Pralidoxime—Nausea—Etoposide—lung cancer	0.000337	0.00377	CcSEcCtD
Pralidoxime—ACHE—Transmission across Chemical Synapses—ADCY1—lung cancer	0.000332	0.00576	CbGpPWpGaD
Pralidoxime—Agitation—Doxorubicin—lung cancer	0.000332	0.00371	CcSEcCtD
Pralidoxime—Nausea—Paclitaxel—lung cancer	0.000331	0.0037	CcSEcCtD
Pralidoxime—BCHE—Transmission across Chemical Synapses—GNG11—lung cancer	0.00033	0.00572	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—CHRNA5—lung cancer	0.000328	0.00568	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—PLBD1—lung cancer	0.000322	0.00559	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—EIF2B4—lung cancer	0.000313	0.00542	CbGpPWpGaD
Pralidoxime—Dizziness—Docetaxel—lung cancer	0.000312	0.00349	CcSEcCtD
Pralidoxime—Somnolence—Methotrexate—lung cancer	0.000302	0.00338	CcSEcCtD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—ANXA1—lung cancer	0.000302	0.00523	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—CHRNA3—lung cancer	0.0003	0.00519	CbGpPWpGaD
Pralidoxime—BCHE—Transmission across Chemical Synapses—ADCY1—lung cancer	0.000297	0.00514	CbGpPWpGaD
Pralidoxime—Headache—Docetaxel—lung cancer	0.000296	0.00331	CcSEcCtD
Pralidoxime—ACHE—ATF-2 transcription factor network—CXCL8—lung cancer	0.000292	0.00507	CbGpPWpGaD
Pralidoxime—Pain—Methotrexate—lung cancer	0.000291	0.00325	CcSEcCtD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—PLBD1—lung cancer	0.000288	0.00499	CbGpPWpGaD
Pralidoxime—Tachycardia—Doxorubicin—lung cancer	0.000288	0.00321	CcSEcCtD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—APP—lung cancer	0.000286	0.00496	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—GNG11—lung cancer	0.000283	0.00491	CbGpPWpGaD
Pralidoxime—ACHE—Peptide hormone metabolism—POMC—lung cancer	0.000282	0.00489	CbGpPWpGaD
Pralidoxime—Nausea—Docetaxel—lung cancer	0.00028	0.00313	CcSEcCtD
Pralidoxime—BCHE—Metabolism of proteins—EIF2B4—lung cancer	0.000279	0.00484	CbGpPWpGaD
Pralidoxime—ACHE—ATF-2 transcription factor network—CCND1—lung cancer	0.000272	0.00472	CbGpPWpGaD
Pralidoxime—ACHE—ATF-2 transcription factor network—JUN—lung cancer	0.000272	0.00471	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—JUNB—lung cancer	0.000271	0.00469	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—CHRNA3—lung cancer	0.000267	0.00463	CbGpPWpGaD
Pralidoxime—Somnolence—Doxorubicin—lung cancer	0.000262	0.00293	CcSEcCtD
Pralidoxime—ACHE—Metabolism of proteins—KHSRP—lung cancer	0.000255	0.00442	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—ADCY1—lung cancer	0.000255	0.00442	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—GNG11—lung cancer	0.000253	0.00438	CbGpPWpGaD
Pralidoxime—Pain—Doxorubicin—lung cancer	0.000252	0.00282	CcSEcCtD
Pralidoxime—BCHE—Peptide hormone metabolism—POMC—lung cancer	0.000252	0.00437	CbGpPWpGaD
Pralidoxime—ACHE—ATF-2 transcription factor network—EP300—lung cancer	0.000251	0.00435	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—MTMR3—lung cancer	0.000251	0.00435	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—STK11—lung cancer	0.000246	0.00426	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—KIF5B—lung cancer	0.000245	0.00425	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—KHSRP—lung cancer	0.000227	0.00394	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—ADCY1—lung cancer	0.000227	0.00394	CbGpPWpGaD
Pralidoxime—Dizziness—Methotrexate—lung cancer	0.000225	0.00252	CcSEcCtD
Pralidoxime—ACHE—ATF-2 transcription factor network—MAPK3—lung cancer	0.000225	0.0039	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—MTMR3—lung cancer	0.000224	0.00388	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—EIF2B5—lung cancer	0.000223	0.00386	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—KIF5B—lung cancer	0.000219	0.00379	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—ABCB1—lung cancer	0.000215	0.00373	CbGpPWpGaD
Pralidoxime—Headache—Methotrexate—lung cancer	0.000213	0.00238	CcSEcCtD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—TYMS—lung cancer	0.000211	0.00367	CbGpPWpGaD
Pralidoxime—Nausea—Methotrexate—lung cancer	0.000202	0.00226	CcSEcCtD
Pralidoxime—ACHE—Phospholipid metabolism—PIK3CG—lung cancer	0.000201	0.00349	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—EIF2B5—lung cancer	0.000199	0.00345	CbGpPWpGaD
Pralidoxime—Dizziness—Doxorubicin—lung cancer	0.000195	0.00218	CcSEcCtD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—FASLG—lung cancer	0.000194	0.00337	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—COL4A3BP—lung cancer	0.00019	0.00329	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—AZIN2—lung cancer	0.00019	0.00329	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—ST3GAL5—lung cancer	0.000189	0.00328	CbGpPWpGaD
Pralidoxime—Headache—Doxorubicin—lung cancer	0.000185	0.00206	CcSEcCtD
Pralidoxime—BCHE—Phospholipid metabolism—PIK3CG—lung cancer	0.00018	0.00311	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—FGFR1—lung cancer	0.000179	0.0031	CbGpPWpGaD
Pralidoxime—ACHE—Phospholipid metabolism—PIK3CD—lung cancer	0.000177	0.00307	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	0.000177	0.00306	CbGpPWpGaD
Pralidoxime—Nausea—Doxorubicin—lung cancer	0.000175	0.00196	CcSEcCtD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	0.000171	0.00297	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—COL4A3BP—lung cancer	0.000169	0.00293	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—AZIN2—lung cancer	0.000169	0.00293	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—ST3GAL5—lung cancer	0.000169	0.00293	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—B4GALT5—lung cancer	0.000169	0.00293	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—ADAMTS1—lung cancer	0.000169	0.00293	CbGpPWpGaD
Pralidoxime—ACHE—ATF-2 transcription factor network—IL6—lung cancer	0.000164	0.00285	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ATP5H—lung cancer	0.000161	0.00279	CbGpPWpGaD
Pralidoxime—BCHE—Phospholipid metabolism—PIK3CD—lung cancer	0.000158	0.00274	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	0.000158	0.00273	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—APC—lung cancer	0.000155	0.00269	CbGpPWpGaD
Pralidoxime—ACHE—Phospholipid metabolism—PIK3CB—lung cancer	0.000154	0.00267	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—EGF—lung cancer	0.000153	0.00266	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	0.000153	0.00265	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—ADAMTS1—lung cancer	0.000151	0.00261	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—B4GALT5—lung cancer	0.000151	0.00261	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	0.000148	0.00257	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—GRP—lung cancer	0.000148	0.00256	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—CASP8—lung cancer	0.000145	0.00251	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—CREBBP—lung cancer	0.000144	0.00249	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ATP5H—lung cancer	0.000144	0.00249	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PLBD1—lung cancer	0.000144	0.00249	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	0.000141	0.00245	CbGpPWpGaD
Pralidoxime—ACHE—Transmission across Chemical Synapses—BRAF—lung cancer	0.000141	0.00244	CbGpPWpGaD
Pralidoxime—BCHE—Phospholipid metabolism—PIK3CB—lung cancer	0.000138	0.00239	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—MAP2K1—lung cancer	0.000137	0.00238	CbGpPWpGaD
Pralidoxime—ACHE—Phospholipid metabolism—PTEN—lung cancer	0.000133	0.00231	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	0.000132	0.00229	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—GRP—lung cancer	0.000132	0.00229	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—HSD17B10—lung cancer	0.000131	0.00228	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—ATF3—lung cancer	0.000129	0.00223	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PLBD1—lung cancer	0.000128	0.00222	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	0.000126	0.00218	CbGpPWpGaD
Pralidoxime—BCHE—Transmission across Chemical Synapses—BRAF—lung cancer	0.000125	0.00217	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—MDM2—lung cancer	0.000122	0.00212	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CKB—lung cancer	0.000122	0.00212	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—RAF1—lung cancer	0.000122	0.00211	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—ERBB2—lung cancer	0.00012	0.00209	CbGpPWpGaD
Pralidoxime—BCHE—Phospholipid metabolism—PTEN—lung cancer	0.000119	0.00206	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—lung cancer	0.000118	0.00204	CbGpPWpGaD
Pralidoxime—ACHE—Transmission across Chemical Synapses—MDM2—lung cancer	0.000118	0.00204	CbGpPWpGaD
Pralidoxime—ACHE—Transmission across Chemical Synapses—RAF1—lung cancer	0.000117	0.00204	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—HSD17B10—lung cancer	0.000117	0.00203	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—LMNA—lung cancer	0.000116	0.00201	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—ATF3—lung cancer	0.000115	0.00199	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—GSTM2—lung cancer	0.000115	0.00199	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CNDP2—lung cancer	0.000115	0.00199	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—MTMR3—lung cancer	0.000112	0.00194	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—CASP3—lung cancer	0.000109	0.0019	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CKB—lung cancer	0.000109	0.00189	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PGAM1—lung cancer	0.000109	0.00189	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—BRAF—lung cancer	0.000108	0.00187	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—CCND1—lung cancer	0.000106	0.00185	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—JUN—lung cancer	0.000106	0.00184	CbGpPWpGaD
Pralidoxime—BCHE—Transmission across Chemical Synapses—MDM2—lung cancer	0.000105	0.00182	CbGpPWpGaD
Pralidoxime—BCHE—Transmission across Chemical Synapses—RAF1—lung cancer	0.000105	0.00182	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CYP2A7—lung cancer	0.000104	0.0018	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—LMNA—lung cancer	0.000103	0.00179	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	0.000103	0.00179	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	0.000103	0.00178	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—GSTM2—lung cancer	0.000102	0.00178	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CNDP2—lung cancer	0.000102	0.00178	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—SDC4—lung cancer	0.000102	0.00176	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—MTMR3—lung cancer	9.96e-05	0.00173	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	9.8e-05	0.0017	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PGAM1—lung cancer	9.71e-05	0.00168	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—BRAF—lung cancer	9.61e-05	0.00167	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	9.53e-05	0.00165	CbGpPWpGaD
Pralidoxime—ACHE—Phospholipid metabolism—PIK3CA—lung cancer	9.4e-05	0.00163	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	9.28e-05	0.00161	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CYP2A7—lung cancer	9.26e-05	0.00161	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—RRM1—lung cancer	9.25e-05	0.0016	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—GSTA3—lung cancer	9.25e-05	0.0016	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—SDC4—lung cancer	9.06e-05	0.00157	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—MDM2—lung cancer	9.03e-05	0.00156	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—RAF1—lung cancer	8.99e-05	0.00156	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	8.78e-05	0.00152	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—B4GALT5—lung cancer	8.7e-05	0.00151	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	8.54e-05	0.00148	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—GSTA4—lung cancer	8.46e-05	0.00147	CbGpPWpGaD
Pralidoxime—BCHE—Phospholipid metabolism—PIK3CA—lung cancer	8.39e-05	0.00145	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	8.35e-05	0.00145	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	8.27e-05	0.00143	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—GSTA3—lung cancer	8.26e-05	0.00143	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—RRM1—lung cancer	8.26e-05	0.00143	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—GSTA2—lung cancer	8.25e-05	0.00143	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—MDM2—lung cancer	8.05e-05	0.0014	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—RAF1—lung cancer	8.02e-05	0.00139	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—GSTA1—lung cancer	7.96e-05	0.00138	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	7.89e-05	0.00137	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ABCC3—lung cancer	7.87e-05	0.00136	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—B4GALT5—lung cancer	7.76e-05	0.00135	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—AKR1C1—lung cancer	7.62e-05	0.00132	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—GSTA4—lung cancer	7.55e-05	0.00131	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—UGT1A1—lung cancer	7.4e-05	0.00128	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	7.38e-05	0.00128	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—GSTA2—lung cancer	7.36e-05	0.00128	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	7.25e-05	0.00126	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—GNG11—lung cancer	7.13e-05	0.00124	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—GSTA1—lung cancer	7.1e-05	0.00123	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—APOA1—lung cancer	7.1e-05	0.00123	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ABCC3—lung cancer	7.02e-05	0.00122	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	7.01e-05	0.00122	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—AKR1C1—lung cancer	6.8e-05	0.00118	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ALDOA—lung cancer	6.79e-05	0.00118	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—UGT1A1—lung cancer	6.6e-05	0.00114	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—NCOA3—lung cancer	6.59e-05	0.00114	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	6.48e-05	0.00112	CbGpPWpGaD
Pralidoxime—ACHE—Transmission across Chemical Synapses—HRAS—lung cancer	6.46e-05	0.00112	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ABCG2—lung cancer	6.41e-05	0.00111	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ADCY1—lung cancer	6.41e-05	0.00111	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—MMP1—lung cancer	6.41e-05	0.00111	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—GNG11—lung cancer	6.36e-05	0.0011	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—APOA1—lung cancer	6.33e-05	0.0011	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—HPGDS—lung cancer	6.29e-05	0.00109	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ENO2—lung cancer	6.29e-05	0.00109	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PPP2R1B—lung cancer	6.25e-05	0.00108	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—POMC—lung cancer	6.17e-05	0.00107	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—GSTT1—lung cancer	6.1e-05	0.00106	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ALDOA—lung cancer	6.06e-05	0.00105	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CYP2A6—lung cancer	6.03e-05	0.00105	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—GCLC—lung cancer	6.03e-05	0.00105	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	6.01e-05	0.00104	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	5.92e-05	0.00103	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—NCOA3—lung cancer	5.88e-05	0.00102	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	5.78e-05	0.001	CbGpPWpGaD
Pralidoxime—BCHE—Transmission across Chemical Synapses—HRAS—lung cancer	5.77e-05	0.001	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ADCY1—lung cancer	5.72e-05	0.000992	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ABCG2—lung cancer	5.72e-05	0.000992	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—MMP1—lung cancer	5.72e-05	0.000992	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ENO1—lung cancer	5.72e-05	0.000991	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	5.7e-05	0.000988	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—ALB—lung cancer	5.62e-05	0.000975	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ENO2—lung cancer	5.61e-05	0.000973	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—HPGDS—lung cancer	5.61e-05	0.000973	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PPP2R1B—lung cancer	5.58e-05	0.000967	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—POMC—lung cancer	5.5e-05	0.000954	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—GSTT1—lung cancer	5.44e-05	0.000944	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CYP2A6—lung cancer	5.38e-05	0.000933	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—GCLC—lung cancer	5.38e-05	0.000933	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	5.36e-05	0.000929	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—POMC—lung cancer	5.33e-05	0.000924	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CYP2E1—lung cancer	5.13e-05	0.000889	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ENO1—lung cancer	5.1e-05	0.000884	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	5.08e-05	0.000881	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—NQO1—lung cancer	5.07e-05	0.000879	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—ALB—lung cancer	5.02e-05	0.00087	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	4.97e-05	0.000861	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—MMP2—lung cancer	4.96e-05	0.00086	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—HRAS—lung cancer	4.95e-05	0.000859	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	4.92e-05	0.000853	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—POMC—lung cancer	4.75e-05	0.000824	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CYP2E1—lung cancer	4.58e-05	0.000793	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—STK11—lung cancer	4.57e-05	0.000792	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—NQO1—lung cancer	4.52e-05	0.000784	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	4.43e-05	0.000768	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—MMP2—lung cancer	4.43e-05	0.000767	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—HRAS—lung cancer	4.42e-05	0.000766	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	4.39e-05	0.000761	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—PTEN—lung cancer	4.29e-05	0.000744	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—GSTP1—lung cancer	4.23e-05	0.000733	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—CXCL8—lung cancer	4.12e-05	0.000715	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CAT—lung cancer	4.12e-05	0.000714	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—EP300—lung cancer	4.09e-05	0.000709	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—STK11—lung cancer	4.08e-05	0.000707	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ABCB1—lung cancer	4e-05	0.000694	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—TYMS—lung cancer	3.93e-05	0.000682	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—GSTM1—lung cancer	3.89e-05	0.000674	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—PTEN—lung cancer	3.83e-05	0.000664	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—GSTP1—lung cancer	3.77e-05	0.000654	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CYP1A1—lung cancer	3.68e-05	0.000639	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—CXCL8—lung cancer	3.68e-05	0.000638	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CAT—lung cancer	3.67e-05	0.000637	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ERCC2—lung cancer	3.65e-05	0.000634	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—EP300—lung cancer	3.65e-05	0.000633	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ABCB1—lung cancer	3.57e-05	0.000619	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—TYMS—lung cancer	3.51e-05	0.000608	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—GSTM1—lung cancer	3.47e-05	0.000601	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CYP1A1—lung cancer	3.29e-05	0.00057	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ERCC2—lung cancer	3.26e-05	0.000565	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—APOA1—lung cancer	3.16e-05	0.000548	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.03e-05	0.000525	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PIK3CG—lung cancer	2.89e-05	0.0005	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—APOA1—lung cancer	2.82e-05	0.000489	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—POMC—lung cancer	2.75e-05	0.000476	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.7e-05	0.000468	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CREBBP—lung cancer	2.68e-05	0.000464	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PIK3CG—lung cancer	2.57e-05	0.000446	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PIK3CD—lung cancer	2.54e-05	0.00044	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ALB—lung cancer	2.5e-05	0.000434	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—POMC—lung cancer	2.45e-05	0.000425	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CREBBP—lung cancer	2.39e-05	0.000414	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PIK3CD—lung cancer	2.26e-05	0.000392	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ALB—lung cancer	2.23e-05	0.000387	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PIK3CB—lung cancer	2.21e-05	0.000383	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PTGS2—lung cancer	2.19e-05	0.00038	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PIK3CB—lung cancer	1.97e-05	0.000342	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PTGS2—lung cancer	1.95e-05	0.000339	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PTEN—lung cancer	1.91e-05	0.000331	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—EP300—lung cancer	1.82e-05	0.000316	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PTEN—lung cancer	1.7e-05	0.000296	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—EP300—lung cancer	1.63e-05	0.000282	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PIK3CA—lung cancer	1.35e-05	0.000234	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PIK3CA—lung cancer	1.2e-05	0.000209	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—AKT1—lung cancer	1.1e-05	0.000191	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—AKT1—lung cancer	9.82e-06	0.00017	CbGpPWpGaD
